|
John Walling, Ph.D. is the Director of Manufacturing Operations at Reata. He brings over 20 years of pharma development experience to the Reata organization. Dr. Walling joined Reata after making significant contributions at Ferro Pfanstiehl Laboratories where he was Director of Chemical and Process Technology. He was instrumental in assisting the company in establishing a successful Fee for Service business strategy and platform focusing on development and commercial manufacturing of cytotoxic and highly potent active pharmaceutical ingredients. Previously, Dr. Walling held positions of increasing responsibility in research, development and manufacturing operations within ILEX Oncology, Cambrex Corporation and Abbott Laboratories. Dr. Walling has a Ph.D. in Organic Chemistry from Iowa State University with a focus on natural products synthetic chemistry. He also holds a RAC certification from the Regulatory Affairs Professionals Society. | 